Expired activity
Please go to the PowerPak homepage and select a course.

HIV/AIDS: A Review for Pharmacy Technicians

This educational activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and is for pharmacy technicians.
There has been no commercial support for this activity.

FACULTY

Jeannette Wick, RPh, MBA, FASCP
Assistant Director, Office of Pharmacy Professional Development and Visiting Instructor
University of Connecticut School of Pharmacy
Storrs, CT

FINANCIAL DISCLOSURE

Jeannette Wick, RPh, MBA, FASCP has no relevant affiliations or financial relationships with a commercial interest to disclose.

The following reviewer, Darrell Hulisz, PharmD hereby states that he does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Susanne Batesko, RN, BSN, Robin Carrino, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

ACCREDITATION STATEMENTS

acpePHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-18-015-H02-T

Credits: 2.0 hours (0.20 ceu)
Published: April 1, 2018
Last Review: March 28, 2020
Expires: April 1, 2021
Type of Activity: Knowledge
Media: Internet

This course is approved by the Florida Board of Pharmacy, provider number 50-17869.
CE Broker Course ID: 20-612405
Postgraduate Healthcare Education, LLC reports registered course completions by Florida license holders to the CE Broker System.

Fee Information: Fee is included in the pharmacy technician package or $4.50.

Estimated time to complete activity: 120 minutes

TARGET AUDIENCE

This accredited activity has been designed for pharmacy technicians.

HOW TO EARN CREDIT

During the period April 1, 2018 through April 30, 2020, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the post-test and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

GOAL

This activity's goal is to provide basic information about HIV and its treatment to pharmacy technicians, and help them recognize the most common problems that patients living with HIV experience.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be better able to:

  1. Summarize the epidemiology, modes of transmission, and most frequent complications of HIV/AIDS
  2. List prevention methods and infection control practices for HIV infection
  3. Describe the HIV lifecycle and clinical management of HIV infection
  4. Identify types of antivirals used to treat HIV and resources to identify drug interactions
  5. Review HIV testing-related requirements of the Florida Omnibus AIDS Act.

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac &/Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Monitor Screen Resolution: 320 x 480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.